Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Biplab Das

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Chemical Communications (Cambridge, England)|January 13, 2009
A lysine walk to high relaxivity collagen-targeted MRI contrast agentsPeter Caravan, Biplab Das, Qing Deng, et al.
Bioanalysis|August 16, 2023
A sensitive LC-MS/MS assay to quantitate free payload Aur0101 from ADC PYX-201 in rat and monkey plasmaFeng Yin, Farah Ahsan, Jan Pinkas, et al.
Bioanalysis|March 6, 2023
Quantification of antibody-drug conjugate PYX-201 in rat and monkey plasma via ELISA and its application in preclinical studiesFeng Yin, Chris DeCiantis, Jan Pinkas, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 11, 2023
Quantitation of total antibody (tAb) from antibody drug conjugate (ADC) PYX-201 in rat and monkey plasma using an enzyme-linked immunosorbent assay (ELISA) and its application in preclinical studiesFeng Yin, Chris DeCiantis, Jan Pinkas, et al.
Cancer Discovery|February 26, 2021
Mobocertinib (TAK-788): A Targeted Inhibitor of <i>EGFR</i> Exon 20 Insertion Mutants in Non-Small Cell Lung CancerFrancois Gonzalvez, Sylvie Vincent, Theresa E Baker, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|December 24, 2024
Geo-spatial analysis of acute ischemic stroke reperfusion treatment in India: An assessment of distribution and access to centersKaiz S Asif, Arun Mitra, Santiago Ortega-Gutierrez, et al.
Nucleic Acids Research|March 2, 2019
Safety evaluation of 2'-deoxy-2'-fluoro nucleotides in GalNAc-siRNA conjugatesMaja M Janas, Ivan Zlatev, Ju Liu, et al.
Bioorganic & Medicinal Chemistry Letters|November 24, 2022
Discovery of mobocertinib, a potent, oral inhibitor of EGFR exon 20 insertion mutations in non-small cell lung cancerWei-Sheng Huang, Feng Li, Yongjin Gong, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Chemical Communications (Cambridge, England)|January 13, 2009
A lysine walk to high relaxivity collagen-targeted MRI contrast agentsPeter Caravan, Biplab Das, Qing Deng, et al.
Bioanalysis|August 16, 2023
A sensitive LC-MS/MS assay to quantitate free payload Aur0101 from ADC PYX-201 in rat and monkey plasmaFeng Yin, Farah Ahsan, Jan Pinkas, et al.
Bioanalysis|March 6, 2023
Quantification of antibody-drug conjugate PYX-201 in rat and monkey plasma via ELISA and its application in preclinical studiesFeng Yin, Chris DeCiantis, Jan Pinkas, et al.
Journal of Pharmaceutical and Biomedical Analysis|May 11, 2023
Quantitation of total antibody (tAb) from antibody drug conjugate (ADC) PYX-201 in rat and monkey plasma using an enzyme-linked immunosorbent assay (ELISA) and its application in preclinical studiesFeng Yin, Chris DeCiantis, Jan Pinkas, et al.
Cancer Discovery|February 26, 2021
Mobocertinib (TAK-788): A Targeted Inhibitor of <i>EGFR</i> Exon 20 Insertion Mutants in Non-Small Cell Lung CancerFrancois Gonzalvez, Sylvie Vincent, Theresa E Baker, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|December 24, 2024
Geo-spatial analysis of acute ischemic stroke reperfusion treatment in India: An assessment of distribution and access to centersKaiz S Asif, Arun Mitra, Santiago Ortega-Gutierrez, et al.
Nucleic Acids Research|March 2, 2019
Safety evaluation of 2'-deoxy-2'-fluoro nucleotides in GalNAc-siRNA conjugatesMaja M Janas, Ivan Zlatev, Ju Liu, et al.
Bioorganic & Medicinal Chemistry Letters|November 24, 2022
Discovery of mobocertinib, a potent, oral inhibitor of EGFR exon 20 insertion mutations in non-small cell lung cancerWei-Sheng Huang, Feng Li, Yongjin Gong, et al.
Pageof 3